Skip to main content
. 2016 Sep 16;7(45):73800–73816. doi: 10.18632/oncotarget.12070

Table 1. Clinical-pathological data of colorectal cancer patients.*.

Number of patients n 68
Year of surgery Range 2000-2010
Age (yr) Median (Range) 70 (26 - 87)
Gender
Female, n (%) 26 (38)
Male, n (%) 42 (62)
Site
Colon, n (%) 55 (81)
Rectum, n (%) 13 (19)
Clinical follow-up available n (%) 68 (100)
Follow-up time (mo) Median 62.2
Survival time (mo) Median >160
Outcome
Favorable, n 48
Deceased, n 20
UICC stage
n.a., n (%)# 1 (2)
I, n (%) 11 (16)
II, n (%) 28 (41)
III, n (%) 21 (31)
IV, n (%) 7 (10)
WHO grade
n.a., n (%)# 1 (2)
2, n (%) 45 (66)
3, n (%) 22 (32)
MSI status
Stable, n (%) 57 (84)
Unstable, n (%) 11 (16)
Tissue tumor (T), n 68
non-tumor (N), n 67
mRNA RQ T<N
ESRP1, n (%) 48 of 67 (72)
ESRP2, n (%) 47 of 67 (70)
*

cases (n=4) had two synchronous colorectal carcinomas;

#

case (n=1) with focal high-grade dysplasia in a tubulovillous adenoma with CRC stage and grade not available (n.a)